Clinical trial
A Phase II Study of Nasal NK/T-cell Lymphoma
NCT00292695 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00292695 |
|---|---|
| Title | A Phase II Study of Nasal NK/T-cell Lymphoma |
| Official title | A Phase II Study of Concurrent Chemoradiation for The Localized Nasal NK/T-cell Lymphoma |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Mackay Memorial Hospital National Cheng-Kung University Hospital Taichung Veterans General Hospital Taipei Veterans General Hospital, Taiwan Kaohsiung Veterans General Hospital. National Taiwan… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Other |
| Interventions | VP-16, Cisplatin, Ifosfamide, Dexamethosone, Mesna, IF-RT |
| Enrollment | 33 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Feb 16, 2006 |
| Last update posted | Oct 30, 2013 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: